Introduction: philosophy and psychedelic psychiatry
Philosophical Perspectives on Psychedelic Psychiatry September 13, 2024 DOI: 10.1093/oso/9780192898371.003.0001 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Citations | 1 |
| Key findings | The chapter reviews the history and recent research of psychedelics in psychiatry and outlines philosophical issues addressed by the volume's chapters. |
Abstract
Abstract The chapter undertakes three main tasks. The first is to review, briefly, the history of psychedelics in psychiatry, including the phenomenological and behavioural effects that first led to their being studied for therapeutic purposes. The second is to give an overview of recent research into the safety, efficacy, and therapeutic mechanisms of psychedelic-assisted psychotherapy. The third is to summarize the contributions of each of the chapters collected in this volume and show how they address philosophical issues arising from the new wave of psychedelic psychiatry. The topics of these chapters cluster around three broad themes, in terms of which the volume is organized: ‘Self and Mind’, ‘Science and Psychiatry’, and ‘Ethics and Spirituality’.
Citations in the library
Cites 56
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Interoceptive inference, emotion, and the embodied self Trends in Cognitive Sciences October 12, 2013
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
and 51 more in the library